Hospital for Children, Chennai Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2016
NCT02774044
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Institute of Child health and Hospital for Children, Chennai

Active Ingredients

Drugs in Phase 3 Trials (2)

beractant (survanta) (1 trial)

poractant alfa (curosurf) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Respiratory Distress Syndrome (Phase 3)

Respiratory Distress Syndrome, Newborn (Phase 3)

Syndrome (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 2